Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04556617 |
| Title | PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
| Recruitment | Terminated |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Plexxikon |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago | Chicago | Illinois | 60637 | United States | Details | |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| Columbia University Medical Center | New York | New York | 10032 | United States | Details | |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | United States | Details | |
| Tennessee Oncology/ Sarah Cannon | Nashville | Tennessee | 37203 | United States | Details | |
| Virginia Cancer Specialist | Fairfax | Virginia | 22031 | United States | Details | |
| University of Wisconsin | Madison | Wisconsin | 53792 | United States | Details | |
| Sarah Cannon Research Institute | London | W1G 6AD | United Kingdom | Details |